Sector: Health Care

It’s rare for the world's leading pharmaceutical companies and other partners to work together to tackle an urgent global health issue. It’s time for this to change and our new coordinated effort – unlike previous siloed, disease-by-disease approaches – is the first step.   Read More

Amgen and Celgene, looking to boost oncology offerings, announced separate deals for small biotech companies Thursday, the latest in what analysts expect to be a major wave of biotech mergers.    Read More

As the JPMorgan Health Care conference kicks off this week, one question remains for investors in the biotech space. What’s the next takeover target as large drug makers look to build out their pipeline?   Read More

The "Patient Protection and Affordable Care Act" has been a lightning rod since its inception. Both sides of the aisle have used a different set of numbers to support stances both for and against the law.    Read More

Ahead of the annual “Health Care Super Bowl” next week, the “Fast Money” pros picked a few of their favorite plays.    Read More

We have worried A LOT in the past few years—jobs, money, the stock market—you name it. But guess what? It has yet to be scientifically proven that worrying can fix a problem. So here are 8 tips to help you stop worrying — or, at the very least, to do it properly!   Read More

The “Mad Money” host compares the top two performing S&P stocks of 2011 to determine who the winner is.   Read More

The health care sector had a good year in 2011 — the group was one of only two sectors out of 10 major categories within the S&P 1200 to deliver positive returns on both a price and total return basis. But 2012 brings a new set of challenges, reports TheStreet.com.   Read More

The “Fast Money” traders weighed in on how to play the No. 6 stock in the countdown of the year’s top S&P performers: Humana.    Read More

Option bulls are looking for Stryker to leg higher.   Read More